Febripar IV Infusion contains Paracetamol 1000mg, a widely used analgesic and antipyretic agent indicated for the management of mild to moderate pain and fever. Administered intravenously, Febripar IV provides rapid onset of action, making it suitable for patients who are unable to take oral medications or require immediate relief. Paracetamol works by inhibiting the synthesis of prostaglandins in the central nervous system and through a peripheral action by blocking pain impulse generation, thereby reducing fever and alleviating pain. It is commonly used in clinical settings for postoperative pain, musculoskeletal pain, headaches, dental pain, and febrile conditions. Febripar IV is generally well tolerated, with a low incidence of adverse effects when used at recommended doses; however, overdose can lead to severe hepatotoxicity. The infusion should be administered under medical supervision, with careful consideration of the patient’s liver function and overall health status. Febripar IV is contraindicated in patients with known hypersensitivity to paracetamol or any of its excipients. Proper dosing and adherence to recommended guidelines are essential to ensure safety and efficacy. This formulation offers a convenient and effective option for pain and fever management in hospital and clinical environments.